Michael Murray has become director of clinical operations in the Center for Genomic Health at Yale University School of Medicine. He joins Yale from the Geisinger Health System, where he was director of clinical genomics and was leading the GenomeFIRST return of results program, which is part of Geisinger's MyCode Community Heath Initiative. In his new role at Yale, he will similarly focus on bringing clinical genomics to large patient cohorts.
Heidi Rehm last month became chief genomics officer in the Department of Medicine at Massachusetts General Hospital, where she is part of the Center for Genomic Medicine. In her new role, she will focus on the clinical implementation of genomics. Rehm remains medical director of the Broad Institute's clinical research sequencing platform and an associate professor of pathology at MGH, Brigham and Women's Hospital, and Harvard Medical School. She is also a leader and principal investigator of ClinGen, and a co-leader of the Broad Center for Mendelian Genomics. Previously, Rehm was the director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine.
Aleksandar Rajkovic has become the first chief genomics officer of the University of California, San Francisco. He joins UCSF from the University of Pittsburgh Medical Center, where he was division director of reproductive genetics. In his new role, Rajkovic will direct the activities of UCSF's existing clinical genomics laboratories, in addition to leading efforts to apply genetics and genomics to clinical care within the health system.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.